2011
DOI: 10.6026/97320630006255
|View full text |Cite
|
Sign up to set email alerts
|

Population coverage analysis of T-Cell epitopes of Neisseria meningitidis serogroup B from Iron acquisition proteins for vaccine design

Abstract: Although the concept of Reverse Vaccinology was first pioneered for sepsis and meningococcal meningitidis causing bacterium, Neisseria meningitides, no broadly effective vaccine against serogroup B meningococcal disease is yet available. In the present investigation, HLA distribution analysis was undertaken to select three most promiscuous T-cell epitopes out of ten computationally validated epitopes of Iron acquisition proteins from Neisseria MC58 by using the population coverage tool of Immune Epitope Databa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
21
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 24 publications
(21 citation statements)
references
References 19 publications
0
21
0
Order By: Relevance
“…Currently, commercial inactivated whole‐virus vaccines are produced by exposing the virus of interest to a cross‐linking agent such as formaldehyde or an alkylating agent such as beta‐propiolactone. Incorporating the diversity of predicted epitopes may be useful for computationally optimized design of broadly cross‐reactive vaccine candidates including the development of T‐cell epitope‐based vaccines . With experimental confirmation of true immunogenic CD8+ T‐cell epitopes, the spatial and phylogenetic distribution of conserved and variable epitopes should be integrated into pre‐pandemic planning and vaccine selection to ensure broad reactivity and potential effectiveness.…”
Section: Discussionmentioning
confidence: 99%
“…Currently, commercial inactivated whole‐virus vaccines are produced by exposing the virus of interest to a cross‐linking agent such as formaldehyde or an alkylating agent such as beta‐propiolactone. Incorporating the diversity of predicted epitopes may be useful for computationally optimized design of broadly cross‐reactive vaccine candidates including the development of T‐cell epitope‐based vaccines . With experimental confirmation of true immunogenic CD8+ T‐cell epitopes, the spatial and phylogenetic distribution of conserved and variable epitopes should be integrated into pre‐pandemic planning and vaccine selection to ensure broad reactivity and potential effectiveness.…”
Section: Discussionmentioning
confidence: 99%
“…The conservancy values of selected BCL and CTL epitopes were more than 80%, a standard value to generate broad-spectrum antigenicity, and welldesired criteria for any predicted epitopes (17,37). A potential binder (epitope) should have three characteristics in order to generate strong immunogenicity, (i) an IC50 value of less than 500nM, (ii) percentile rank of below 1.5%, and (iii) population coverage of more than 80% (35,38). We found satisfactory IC50 value and percentile rank in our predicted epitope and population coverage of more than 98%, therefore, could be a potential immunogen against hRSV.…”
Section: Discussionmentioning
confidence: 61%
“…Population coverage is usually used to check whether the predicted final epitope and its HLA alleles can cover a significant percent of the world population or not. The IEDB population coverage tool (http://tools.immuneepitope.org/tools/pop ulation/iedb) was used to calculate the cumulative percent of world wide population coverage for the final predicted epitope for both MHC classes, as described previously (35).…”
Section: Population Coveragementioning
confidence: 99%
“…Immunome‐derived vaccines approach is well suited only when there is sequence conservation within species variants . Identification and selection of T‐cell epitopes for cytolytic and regulatory responses to pathogen thus form an important part of vaccine development . Epitope‐based vaccines for HIV, tuberculosis, and malaria have proved promising in clinical trials supporting thereby the importance of T‐cell epitope selection as useful vaccine targets …”
Section: Introductionmentioning
confidence: 99%
“…3,4 Identification and selection of T-cell epitopes for cytolytic and regulatory responses to pathogen thus form an important part of vaccine development. [5][6][7][8] Epitope-based vaccines for HIV, tuberculosis, and malaria have proved promising in clinical trials supporting thereby the importance of T-cell epitope selection as useful vaccine targets. 9,10 Neisseria meningitidis, a human-specific bacterial pathogen causes bacterial meningitis (brain fever) by invading the meninges (outer lining) of central nervous system through bloodstream 11 ( Figure S1 in the Supporting Information).…”
Section: Introductionmentioning
confidence: 99%